Social program in support of patients with multilocular sclerosis and hemophilia

RIA “Novosti” hosted 27 October to a press conference held by Bayer Schering Pharma initiated to the launch of the “Life Rainbow” social program aimed at improvement of life quality for patients suffering with hemophilia and multilocular sclerosis.

In line with the program the patients suffering with these diseases are given all-round support: innovative medications, conditions for professional knowledge advance and patient social adaptation.

Today “Life Rainbow” includes: realization of educational programs for neurologists and hematologists with the participation of leading Russian and foreign specialists in treatment of multilocular sclerosis and hemophilia; organization of patronage nursing services (Beta+) for patients with multilocular sclerosis); free provision of injectors facilitating the drug administration and other means of comfortable therapy; programs of physical and psychological rehabilitation of patients with the said diseases; support of creative abilities of kids suffering with hemophilia, and kids from families having sick members with multilocular sclerosis; organization of traveling thematic photographic exhibitions and children art expositions.

In line with preparation and realization of the press conference, PR-Premier provided the full range of activities with the media.

Client: Bayer